BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7986181)

  • 1. A brief history of the use of interferons as treatment of multiple sclerosis.
    Jacobs L; Johnson KP
    Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
    Sim IS; Cerruti RL
    Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons and multiple sclerosis.
    Clanet M; Blancher A; Calvas P; Rascol O
    Biomed Pharmacother; 1989; 43(5):355-60. PubMed ID: 2477075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.
    van der Meide PH; Harteveld N; Stebbing N; Schellekens H
    Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferons in dermatology.
    Stadler R; Mayer-da-Silva A; Bratzke B; Garbe C; Orfanos C
    J Am Acad Dermatol; 1989 Apr; 20(4):650-6. PubMed ID: 2497154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications for clinical application of new developments in interferon research.
    Taylor-Papadimitriou J; Balkwill FR
    Biochim Biophys Acta; 1982 Sep; 695(1):49-67. PubMed ID: 6182911
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
    Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N
    Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferons--biologic principles and clinical uses].
    Jacobsen H; Kirchner H
    Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interferon system as a basis for antiviral therapy or prophylaxis.
    Billiau A
    Antiviral Res; 1985; Suppl 1():131-40. PubMed ID: 3936410
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of clonogenic assays in assessing the response of human lung cancer cell lines to alpha and gamma interferons alone or in combination with adriamycin.
    Jabbar SA; Twentyman PR
    Int J Cancer; 1990 Sep; 46(3):546-51. PubMed ID: 2118486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.
    Bartsch HH; Pfizenmaier K; Hanusch A; Scheurich P; Ucer U; Nagel GA
    Int J Cancer; 1989 Feb; 43(2):235-40. PubMed ID: 2521842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of human breast cancer xenografts using natural interferons-alpha and -gamma injected singly or in combination.
    Ozzello L; Habif DV; De Rosa CM; Cantell K
    J Interferon Res; 1988 Oct; 8(5):679-90. PubMed ID: 3148672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1984; 13():176-84. PubMed ID: 6085167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical uses of interferons.
    Friedman RM
    Br J Clin Pharmacol; 2008 Feb; 65(2):158-62. PubMed ID: 18070219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.